NCT01097486View on ClinicalTrials.gov

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2014

Conditions
Cervical Degenerative Disc DiseaseDegenerative SpondylolisthesisSpinal Stenosis
Interventions
BIOLOGICAL

NeoFuse

Single Dose NeoFuse Surgical Implantation

PROCEDURE

Allograft

Single Dose Allograft Surgical Implantation

Trial Locations (8)

28204

Carolina Neurosurgery and Spine Associates, Charlotte

32308

Tallahassee Neurological Clinic, P.A., Tallahassee

46804

Fort Wayne Orthopaedics, Fort Wayne

78705

Central Texas Spine Institute, Austin

80111

Denver Spine, Denver

80538

Rocky Mountain Associates in Orthopedic Medicine, P.C., Loveland

90403

The Spine Institute, Santa Monica

95816

UC Davis Spine Center, Sacramento

Sponsors

Lead Sponsor

Mesoblast, Ltd.
All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY

NCT01097486 - Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy | Biotech Hunter | Biotech Hunter